Intervention not reported
Placental parasitaemia (at delivery) · HIV‐positive pregnant women living
The intervention may leads to lower placental parasitaemia (at delivery) (low certainty).
1 finding from 1 review
Intervention not reported
Maternal anaemia (Hb < 11 g/dL at delivery) · HIV‐positive pregnant women living
The intervention showed no clear difference in maternal anaemia (Hb < 11 g/dL at delivery) (low certainty).
1 finding from 1 review
Intervention not reported
Low birth weight (< 2.5 kg) · HIV‐positive pregnant women living
The intervention showed no clear difference in low birth weight (< 2.5 kg) (low certainty).
1 finding from 1 review
Intervention not reported
Neonatal mortality · HIV‐positive pregnant women living
It is very uncertain whether the intervention changes neonatal mortality (very low certainty).
1 finding from 1 review
Intervention not reported
Maternal parasitaemia (at delivery) · HIV‐positive pregnant women
It is very uncertain whether the intervention changes maternal parasitaemia (at delivery) (very low certainty).
1 finding from 1 review
Intervention not reported
Placental parasitaemia (at delivery) · HIV‐positive pregnant women
It is very uncertain whether the intervention changes placental parasitaemia (at delivery) (very low certainty).
1 finding from 1 review
Intervention not reported
Maternal anaemia (Hb < 11 g/dL at delivery) · HIV‐positive pregnant women
It is very uncertain whether the intervention changes maternal anaemia (Hb < 11 g/dL at delivery) (very low certainty).
1 finding from 1 review
Intervention not reported
Low birth weight (< 2.5 kg) · HIV‐positive pregnant women
It is very uncertain whether the intervention changes low birth weight (< 2.5 kg) (very low certainty).
1 finding from 1 review
Intervention not reported
How many people get cholera during the first 2 years after vaccination? · Adults and children
1 finding from 1 review
Intervention not reported
How long does the protection last? · Adults and children
1 finding from 1 review
Intervention not reported
Are there any side effects? · Adults and children
1 finding from 1 review
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether antibiotic changes diarrhoea on compared with no drug or placebo (very low certainty).
2 findings from 1 review
Other adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes diarrhoea on compared with macrolides (very low certainty).
1 finding from 1 review
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with macrolides (very low certainty).
1 finding from 1 review
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether cotrimoxazole changes diarrhoea on compared with beta‐lactams (very low certainty).
1 finding from 1 review
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found